Muscle-Specific PPARβ/δ Agonism May Provide Synergistic Benefits with Life Style Modifications
2007

Muscle-Specific PPARβ/δ Agonism and Its Benefits

publication Evidence: moderate

Author Information

Author(s): Erol Adnan

Primary Institution: Department of Internal Medicine, Faculty of Medicine, Celal Bayar University, Manisa, Turkey

Hypothesis

Muscle-specific PPARβ/δ agonists could be a key strategy to support the poor cardiorespiratory fitness associated with metabolic disorders.

Conclusion

Targeting PPARβ/δ in skeletal muscle may help prevent metabolic disorders like insulin resistance and obesity by enhancing lipid catabolism.

Supporting Evidence

  • Activation of PPARβ/δ enhances mitochondrial capacity and fat oxidation in skeletal muscle.
  • PPARβ/δ is expressed at higher levels in skeletal muscle compared to other tissues.
  • Muscle-specific PPARβ/δ overexpression promotes a shift toward smaller adipocyte size.

Takeaway

This study suggests that a special type of medicine can help muscles use fat better, which might help people who don't exercise much stay healthy.

Digital Object Identifier (DOI)

10.1155/2007/30578

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication